Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
SAN JOSE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ('Rani Therapeutics”; 'Rani” or the 'Company”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported that it granted an equity award in the form of a stock option to purchase 2,000,000 shares of Rani Class A common stock to Nicholas Maestas, Rani’s new Chief Financial Officer, as an inducement material to his acceptance of employment with Rani.
Ähnliche Seiten
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/10/tmt-newswire/globenewswire/context-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4/2362175
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/tenaya-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2384654Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/23/tmt-newswire/globenewswire/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2350373Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/20/tmt-newswire/globenewswire/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2369285Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357297